Kewaunee Scientific Corporation
Organization details
- Legal name
- Kewaunee Scientific Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 3821 — Laboratory Apparatus & Furniture
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Statesville
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- April
- Ticker symbol
- KEQU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000055529
- EIN
- 38-0715562
Board of directors
-
John Jette Campbell · DirectorSince 2025
-
John Russell · DirectorSince 2023
-
Keith M. Gehl · DirectorSince 2023
-
Margaret B. Pyle · DirectorSince 2023
-
Thomas David Hull III · Director · President & CEOSince 2023
Chief executives
Director election results
Annual meeting of August 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.9%
-
99.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $293,168
- 7 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Batdorff Douglas J. Officer (SVP, Manufacturing Operations) | Option exercise | +7,451 | — | — |
| Jun 30, 2026 | Gardner Donald T. III Officer (Chief Financial Officer) | Option exercise | +21,265 | — | — |
| Jun 30, 2026 | Thomas David Hull III Director, Officer (President & CEO) | Option exercise | +54,388 | — | — |
| Jun 30, 2026 | Phillips Elizabeth D Officer (SVP, People & Culture) | Option exercise | +6,656 | — | — |
| Jun 30, 2026 | Noble Ryan S. Officer (SVP, Sales & Marketing Dev) | Option exercise | +7,206 | — | — |
| Jun 30, 2026 | Ranade Mandar Officer (SVP, IT & Engineering) | Option exercise | +7,227 | — | — |
| Jun 30, 2026 | Batdorff Douglas J. Officer (SVP, Manufacturing Operations) | Sold back to the company | −5,609 | $36.25 | $203,326 |
| Jun 30, 2026 | Gardner Donald T. III Officer (Chief Financial Officer) | Sold back to the company | −12,000 | $36.25 | $435,000 |
| Jun 30, 2026 | Thomas David Hull III Director, Officer (President & CEO) | Sold back to the company | −17,000 | $36.25 | $616,250 |
| Jun 30, 2026 | Phillips Elizabeth D Officer (SVP, People & Culture) | Sold back to the company | −4,995 | $36.25 | $181,069 |
| Jun 30, 2026 | Noble Ryan S. Officer (SVP, Sales & Marketing Dev) | Sold back to the company | −3,000 | $36.25 | $108,750 |
| Jun 30, 2026 | Ranade Mandar Officer (SVP, IT & Engineering) | Sold back to the company | −1,800 | $36.25 | $65,250 |
| Jun 30, 2026 | Batdorff Douglas J. Officer (SVP, Manufacturing Operations) | Shares withheld for tax | −851 | $36.25 | $30,849 |
| Jun 30, 2026 | Gardner Donald T. III Officer (Chief Financial Officer) | Shares withheld for tax | −4,027 | $36.25 | $145,979 |
| Jun 30, 2026 | Thomas David Hull III Director, Officer (President & CEO) | Shares withheld for tax | −16,243 | $36.25 | $588,809 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Kewaunee Scientific Corporation
Who is the CEO of Kewaunee Scientific Corporation?
Thomas David Hull III is Kewaunee Scientific Corporation's President, CEO.
How many directors are on Kewaunee Scientific Corporation's board?
Kewaunee Scientific Corporation's board has 5 directors: John Jette Campbell, John Russell, Keith M. Gehl, Margaret B. Pyle and Thomas David Hull III.
Are Kewaunee Scientific Corporation insiders buying or selling shares?
Over the last 12 months, Kewaunee Scientific Corporation insiders made no open-market purchases and sold $293,168 of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="kewaunee-scientific-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.